Atelerix
Atelerix is a biotech company specializing in hypothermic gel-based technology for room temperature preservation of live cells, tissues, and viruses. Their innovative solutions aim to replace traditional cryogenic storage, reducing environmental impact and logistical complexity. Their technology supports research, clinical trials, and biopharmaceutical development by enabling easier, more sustainable, and cost-effective biological transport and storage.
Industries
Nr. of Employees
small (1-50)
Atelerix
Newcastle, Newcastle upon Tyne, United Kingdom, Europe
Patents
Products
Hydrogel vial formulation for short-term cell and viral preservation
A vial-ready alginate hydrogel formulation designed to encapsulate large numbers of cells or viral material for short-term hypothermic storage and transport, intended for scalable and automatable workflows.
Formulations for apheresis and PBMC stabilization
Preservation formulations optimized for leukapheresis products and PBMC-enriched material to maintain monocyte and T cell viability and metabolic function during refrigerated storage and transport.
Tissue stabilization formulation for fresh clinical samples
Formulation for short-term preservation of freshly excised tissues at ambient or refrigerated conditions that preserves histological integrity, epitope presentation and nucleic acid yield for diagnostics and model generation.
Bead and plate-format hydrogel kits for bioprinting and sample shipment
Bead and well-format hydrogel kits that enable room-temperature storage of encapsulated cells and subsequent degelation and reformulation into bioinks for 3D bioprinting or for distribution as pre-packaged microenvironments.
Viral and swab sample preservation formulation
Preservation media and formats for swabs and viral samples designed to maintain viral function and extracellular nucleic acid integrity at ambient temperature for extended surveillance and vector distribution use-cases.
Hydrogel vial formulation for short-term cell and viral preservation
A vial-ready alginate hydrogel formulation designed to encapsulate large numbers of cells or viral material for short-term hypothermic storage and transport, intended for scalable and automatable workflows.
Formulations for apheresis and PBMC stabilization
Preservation formulations optimized for leukapheresis products and PBMC-enriched material to maintain monocyte and T cell viability and metabolic function during refrigerated storage and transport.
Tissue stabilization formulation for fresh clinical samples
Formulation for short-term preservation of freshly excised tissues at ambient or refrigerated conditions that preserves histological integrity, epitope presentation and nucleic acid yield for diagnostics and model generation.
Bead and plate-format hydrogel kits for bioprinting and sample shipment
Bead and well-format hydrogel kits that enable room-temperature storage of encapsulated cells and subsequent degelation and reformulation into bioinks for 3D bioprinting or for distribution as pre-packaged microenvironments.
Viral and swab sample preservation formulation
Preservation media and formats for swabs and viral samples designed to maintain viral function and extracellular nucleic acid integrity at ambient temperature for extended surveillance and vector distribution use-cases.
Services
Establishing distribution agreements and regional reseller relationships to deliver preservation kits and local commercial support.
Provision of preservation sample kits and technical consultation to evaluate, integrate and optimize hydrogel-based hypothermic workflows for specific cell types and applications; free sample kits offered for initial evaluation.
Co-development agreements and pilot studies with academic and industry partners to adapt formulations, perform external validation and generate use-case specific data.
Establishing distribution agreements and regional reseller relationships to deliver preservation kits and local commercial support.
Provision of preservation sample kits and technical consultation to evaluate, integrate and optimize hydrogel-based hypothermic workflows for specific cell types and applications; free sample kits offered for initial evaluation.
Co-development agreements and pilot studies with academic and industry partners to adapt formulations, perform external validation and generate use-case specific data.
Expertise Areas
- Short-term hypothermic and ambient-temperature biopreservation
- Stabilization and transport of cellular materials for research and cell therapy workflows
- Preservation of viral particles and extracellular nucleic acids for surveillance and vector distribution
- Assay-ready sample preparation and multiwell/plate-format shipment
Key Technologies
- Alginate-based hydrogel encapsulation
- Hypothermic preservation (ambient to refrigerated, ~2–25°C)
- Ambient-temperature transport workflows
- Bead and microencapsulation for sample storage
News & Updates
The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) collaborates with Atelerix to develop room temperature storage of cells for research and therapy.
Atelerix partners with MineBio to bring ambient-temperature cell preservation solutions to China, expanding global access and reducing cold chain logistics.
A collaboration to expand sales and distribution of Atelerix’s room temperature preservation technology in North America.
A new solution extending the shelf life of whole blood up to three days at refrigerated temperatures, without cryopreservation.
The company is a finalist in both the Start-Up and Sustainability categories, recognizing its innovative and environmentally responsible solutions.
An article discussing the economic benefits of Atelerix’s room temperature preservation technology compared to traditional cryopreservation.
The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) collaborates with Atelerix to develop room temperature storage of cells for research and therapy.
Atelerix partners with MineBio to bring ambient-temperature cell preservation solutions to China, expanding global access and reducing cold chain logistics.
A collaboration to expand sales and distribution of Atelerix’s room temperature preservation technology in North America.
A new solution extending the shelf life of whole blood up to three days at refrigerated temperatures, without cryopreservation.
The company is a finalist in both the Start-Up and Sustainability categories, recognizing its innovative and environmentally responsible solutions.
An article discussing the economic benefits of Atelerix’s room temperature preservation technology compared to traditional cryopreservation.